Cytogenetic findings and clinical outcomes of adult acute myeloid leukaemia patients

Clinical and Experimental Medicine

Volumn 7, Issue 3, 2007, Pages 102-107

  Sahin, F Iffet ^a   Kizilkilic, E ^a   Bulakbasi, T ^a   Yilmaz, Z ^a   Boga, C ^a   Ozalp, O ^a   Karakus, S ^a   Ozdogu, H ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Acute myeloid leukaemia; Cytogenetics; FISH; Prognosis

Indexed keywords

CYTARABINE; IDARUBICIN; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER REGRESSION; CAUSE OF DEATH; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; HUMAN CELL; KARYOTYPE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYTOGENETICS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REMISSION INDUCTION; SURVIVAL RATE; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 35748942894     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-007-0130-2     Document Type: Article

References (13)

1. Mrozek K, Heerema NA, Bloomfield CD (2004) Cytogenetics in acute leukemia. Blood Rev 18:115-136
2. Hiddemann W, Spiekermann K, Buske C et al (2005) Towards a pathogenesis-oriented therapy of acute myeloid leukemia. Crit Rev Oncol Hematol 56:235-245
3. Marcucci G, Mrozek K, Bloomfield CD (2004) Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics. Curr Opin Hematol 12:68-75
4. Shaffer LG, Tommerup N (2005) An International System for Human Cytogenetic Nomenclature. Karger, Basel, Freiurg, Paris
5. Avivi I, Rowe JM (2004) Prognostic factors in acute myeloid leukemia. Curr Opin Hematol 12:62-67
6. Grimwade D, Walker H, Oliver F et al (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. Blood 92:2322-2333
7. Mrozek K, Prior TW, Edwards C et al (2001) Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol 19:2482-2492
8. Bagg A (2003) Clinical applications of molecular testing in hematologic malignancies: advantages and limitations. Hum Pathol 34:352-358
9. Tanaka K, Arif M, Eguchi M et al (1999) Interphase fluorescence in situ hybridization overcomes pitfalls of G-banding analysis with special reference to underestimation of chromosomal aberration rates. Cancer Genet Cytogenet 115:32-38
10. Mrozek K, Baldus CD, Marcucci G, Bloomfield CD (2005) Acute myeloid leukemia prognostic factors: from cytogenetics to chip. Hematology (EHA Educ Program) 1:116-122
11. Brown J, Jawad M, Twigg SRF et al (2002) A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay. Blood 99:2526-2531
12. Nakao M, Yokota S, Iwai T et al (1996) Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 10:1911-1918
13. Jiang J, Paez JG, Lee JC et al (2004) Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML. Blood 104:1855-1858